IP Library Granted Patent US 8,945,568
Granted Patent B2
US 8,945,568 · App. 13/866,857 · Granted Feb 3, 2015

Pneumococcal Serotype 6D

Inventors: Moon H. Nahm (Birmingham, AL); In Ho Park (Seoul, KR)
Assignee: The UAB Research Foundation
C12N1/20A61K39/092C07K16/1275C12P19/04C12R1/46G01N33/56944C12Q1/14C12Q1/689A61K2039/6081C07K2317/24G01N2333/3156
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,945,568
App. No.
13/866,857
Granted
Feb 3, 2015
Kind
B2
Abstract

Disclosed is a new and emerging serotype of Streptococcus pneumoniae designated serotype 6D, and assays and monoclonal antibodies useful in identifying same. Also disclosed is a novel pneumococcal polysaccharide with the repeating unit→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→4) ribitol (5→phosphate. This new serotype may be included in pneumococcal vaccines.

Claims (6)

1. An isolated or purified antigen binding molecule that binds to a polysaccharide having the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→4) ribitol (5→phosphate}; wherein the antigen binding molecule is an intact antibody, a Fab, Fab′, F(ab′) 2 or Fv fragment thereof, a CDR portion of an antibody, or a peptide or derivative of an antibody, that binds said polysaccharide repeating unit.

2. An immunoassay kit comprising the antigen binding molecule of claim 1 , wherein the immunoassay differentiates for a capsular polysaccharide having the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→4) ribitol (5→phosphate}.

3. The antigen binding molecule of claim 1 , wherein the molecule is an antibody.

4. A composition comprising at least one antigen binding molecule that binds to a polysaccharide having the repeating unit {→2) glucose 1 (1→3) glucose 2 (1→3) rhamnose (1→4) ribitol (5→phosphate}; wherein the antigen binding molecule is an intact antibody, a Fab, Fab′, F(ab′) 2 or Fv fragment thereof, a CDR portion of an antibody, or a peptide or derivative of an antibody, that binds said polysaccharide repeating unit.

5. The composition of claim 4 , wherein the composition comprises monoclonal or polyclonal antibodies.

6. An immunoassay kit comprising the composition of claim 4 .

Assignments (1)
CONFIRMATORY LICENSE Recorded Aug 24, 2021
From: UNIVERSITY OF ALABAMA AT BIRMINGHAM
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 057279/0084 →
Continuity (4)
Division 12601896
Provisional Application 60924703 · May 29, 2007
Provisional Application 60924704 · May 29, 2007
Related Publication 20130216576A1 · Aug 22, 2013